GB9614022D0 - Antiviral therapeutic combinations - Google Patents

Antiviral therapeutic combinations

Info

Publication number
GB9614022D0
GB9614022D0 GBGB9614022.3A GB9614022A GB9614022D0 GB 9614022 D0 GB9614022 D0 GB 9614022D0 GB 9614022 A GB9614022 A GB 9614022A GB 9614022 D0 GB9614022 D0 GB 9614022D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic combinations
antiviral therapeutic
antiviral
combinations
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9614022.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Priority to GBGB9614022.3A priority Critical patent/GB9614022D0/en
Publication of GB9614022D0 publication Critical patent/GB9614022D0/en
Priority to BR9709939A priority patent/BR9709939A/en
Priority to KR1019980710646A priority patent/KR20000022226A/en
Priority to EA199801045A priority patent/EA001517B1/en
Priority to PCT/EP1997/003247 priority patent/WO1997049411A1/en
Priority to ES97928263T priority patent/ES2213217T3/en
Priority to US09/202,660 priority patent/US6544961B1/en
Priority to CA002258956A priority patent/CA2258956A1/en
Priority to IL12735197A priority patent/IL127351A0/en
Priority to NZ333099A priority patent/NZ333099A/en
Priority to TR1998/02704T priority patent/TR199802704T2/en
Priority to JP10502320A priority patent/JP2000515852A/en
Priority to APAP/P/1998/001419A priority patent/AP9801419A0/en
Priority to EP97928263A priority patent/EP0938321B1/en
Priority to CZ984294A priority patent/CZ429498A3/en
Priority to AU32627/97A priority patent/AU727983B2/en
Priority to ARP970102758A priority patent/AR007616A1/en
Priority to HU9903249A priority patent/HUP9903249A3/en
Priority to AT97928263T priority patent/ATE257708T1/en
Priority to DE69727240T priority patent/DE69727240T2/en
Priority to PE00053497A priority patent/PE87298A1/en
Priority to IDP972147A priority patent/ID19490A/en
Priority to CO97034781A priority patent/CO4900074A1/en
Priority to CN97197357A priority patent/CN1228026A/en
Priority to PL97330747A priority patent/PL330747A1/en
Priority to TW086111193A priority patent/TW469132B/en
Priority to IS4915A priority patent/IS4915A/en
Priority to YU58398A priority patent/YU58398A/en
Priority to NO986034A priority patent/NO986034L/en
Pending legal-status Critical Current

Links

GBGB9614022.3A 1996-06-25 1996-07-04 Antiviral therapeutic combinations Pending GB9614022D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GBGB9614022.3A GB9614022D0 (en) 1996-07-04 1996-07-04 Antiviral therapeutic combinations
PL97330747A PL330747A1 (en) 1996-06-25 1997-06-23 Vx478, zidovudin, ftc and/or 3tc containing combinations for use in treating hiv infections
CZ984294A CZ429498A3 (en) 1996-06-25 1997-06-23 Combination containing vx478, zidovudine, gtc and/or 3tc for treating hiv infection
ARP970102758A AR007616A1 (en) 1996-06-25 1997-06-23 ANTIVIRAL COMBINATIONS
AU32627/97A AU727983B2 (en) 1996-06-25 1997-06-23 Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatment of HIV
PCT/EP1997/003247 WO1997049411A1 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
KR1019980710646A KR20000022226A (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US09/202,660 US6544961B1 (en) 1996-06-25 1997-06-23 Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV
CA002258956A CA2258956A1 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
IL12735197A IL127351A0 (en) 1996-06-25 1997-06-23 Combinations comprising VX478 zidovudine FTC and/or 3TC for use in the treatment of HIV
NZ333099A NZ333099A (en) 1996-06-25 1997-06-23 synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
TR1998/02704T TR199802704T2 (en) 1996-06-25 1997-06-23 Use of combinations containing Vx478, Zidovidin, FTC and/or 3TC in the treatment of HIV.
JP10502320A JP2000515852A (en) 1996-06-25 1997-06-23 A combination comprising VX478, zidovudine, FTC and / or 3TC for use in treating HIV
HU9903249A HUP9903249A3 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
EP97928263A EP0938321B1 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
BR9709939A BR9709939A (en) 1996-06-25 1997-06-23 Combination pharmaceutical formulation process for treating an HIV infection in an infected animal uses 3s acid tetrahydro-3-furanyl ester [3r * (1r *, 2s *)] - [- 3 - [[4-amino-phenyl) sulfonyl] (2-methylpropyl) -amino] -2-hydroxy-1-phenylmethyl) propyl] -carbamic zidovudine and (2r, cis) -4-amino-1- (2-hydroxymethyl-1,3-oxathiolan -5-il) - (1h) -pyrimidin-2-one and patient package
EA199801045A EA001517B1 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
ES97928263T ES2213217T3 (en) 1996-06-25 1997-06-23 COMBINATIONS THAT INCLUDE VX478, ZIDOVUDINA, AND 3TC FOR USE IN THE TREATMENT OF HIV INFECTIONS.
APAP/P/1998/001419A AP9801419A0 (en) 1996-06-25 1997-06-23 Combination comprising VX478, zidovudine, FTC and or 3
AT97928263T ATE257708T1 (en) 1996-06-25 1997-06-23 COMBINATIONS CONTAINING VX478, ZIDOVUDINE AND 3TC FOR THE TREATMENT OF HIV
DE69727240T DE69727240T2 (en) 1996-06-25 1997-06-23 Combinations containing VX478, zidovudine and 3TC for the treatment of HIV
PE00053497A PE87298A1 (en) 1996-06-25 1997-06-23 ANTIVIRAL COMBINATIONS
IDP972147A ID19490A (en) 1996-06-25 1997-06-23 ANTIVIRAL COMBINATIONS
CO97034781A CO4900074A1 (en) 1996-06-25 1997-06-23 ANTIVIRAL COMBINATIONS
CN97197357A CN1228026A (en) 1996-06-25 1997-06-23 Combinations comprising VX 478, zidovudine, FTC and/or 3TC for use in treatment of HIV
TW086111193A TW469132B (en) 1996-06-25 1997-08-05 Antiviral combinations
IS4915A IS4915A (en) 1996-06-25 1998-11-30 Compositions containing VX478, Zidovudine, FTC and / or 3TC for use in the treatment of HIV
YU58398A YU58398A (en) 1996-06-25 1998-12-16 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use the terapy of hiv
NO986034A NO986034L (en) 1996-06-25 1998-12-22 Combinations comprising VX 478, ZidovudÞn, FTC and / or 3TC for use in the treatment of HIV

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9614022.3A GB9614022D0 (en) 1996-07-04 1996-07-04 Antiviral therapeutic combinations

Publications (1)

Publication Number Publication Date
GB9614022D0 true GB9614022D0 (en) 1996-09-04

Family

ID=10796331

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9614022.3A Pending GB9614022D0 (en) 1996-06-25 1996-07-04 Antiviral therapeutic combinations

Country Status (3)

Country Link
AR (1) AR007616A1 (en)
GB (1) GB9614022D0 (en)
PE (1) PE87298A1 (en)

Also Published As

Publication number Publication date
PE87298A1 (en) 1999-01-15
AR007616A1 (en) 1999-11-10

Similar Documents

Publication Publication Date Title
GB9601724D0 (en) Therapeutic agents
GB9413724D0 (en) Therapeutic nucleosides
ZA982368B (en) New therapeutic combinations
GB9600235D0 (en) Therapeutic agents
GB9603755D0 (en) Therapeutic agents
GB9609374D0 (en) Therapeutic agents
GB9605065D0 (en) Therapeutic agents
GB9620777D0 (en) Therapeutic use
GB9723999D0 (en) Therapeutic use
ZA975565B (en) Antiviral combinations
GB9726701D0 (en) Therapeutic use
GB9604036D0 (en) Therapeutic agents
GB9603136D0 (en) Therapeutic agents
ZA977005B (en) Therapeutic uses
GB9614022D0 (en) Antiviral therapeutic combinations
GB9614024D0 (en) Antiviral therapeutic combinations
GB9726702D0 (en) Therapeutic use
GB9615972D0 (en) Sunbed
GB9601786D0 (en) Therapeutic agents
ZA975564B (en) Antiviral combinations
GB9605465D0 (en) Therapeutic use
GB9605523D0 (en) Therapeutic use
GB9620880D0 (en) Therapeutic use
GB9605466D0 (en) Therapy
GB9605525D0 (en) Therapy